Navigation Links
Hospira to Host Conference Call for First-Quarter 2011 Results
Date:4/4/2011

LAKE FOREST, Ill., April 4, 2011 /PRNewswire/ -- Hospira, Inc. (NYSE: HSP), a leading global specialty pharmaceutical and medication delivery company, today announced that it will host a conference call to discuss its first-quarter 2011 results on Tuesday, April 26, 2011 at 8 a.m. Central time.

The company will release its first-quarter results earlier that morning, before the U.S. stock market open and the conference call.

A live webcast of the conference call and related material will be available on Hospira's Web site at www.hospirainvestor.com. Listeners should log on approximately 10 minutes in advance to ensure proper setup to receive the webcast. A replay will be available on the Hospira Web site for 30 days following the call.

About Hospira

Hospira, Inc. is a global specialty pharmaceutical and medication delivery company dedicated to Advancing Wellness™. As the world leader in specialty generic injectable pharmaceuticals, Hospira offers one of the broadest portfolios of generic acute-care and oncology injectables, as well as integrated infusion therapy and medication management solutions. Through its products, Hospira helps improve the safety, cost and productivity of patient care. The company is headquartered in Lake Forest, Ill., and has approximately 14,000 employees. Learn more at www.hospira.com.


'/>"/>
SOURCE Hospira, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Hospira Submits 510(k) Application to FDA for Symbiq™ Infusion System Modifications
2. Hospira Launches Enhanced TheraDoc™ Clinical Surveillance System to Support Patient Safety and Help Improve Care
3. Hologic, Hospira, Boston Scientific, Allergan to Participate in Leading Medical Device Manufacturing Symposium
4. Hospira Announces U.S. Approval of Generic Docetaxel
5. Hospira Board Names F. Michael Ball New CEO; Christopher B. Begley to Assume Executive Chairman Role
6. Hospira MedNet™ Portal Safety Software Benchmarking System Debuts at HIMSS
7. Hospira to Present at Upcoming Investor Conferences
8. Hospira Announces FDA Approval of Topotecan Injection
9. Hospira Reports Fourth-Quarter and Full-Year 2010 Results
10. Hospira to Host Conference Call for Fourth-Quarter 2010 Results and 2011 Projections
11. Hospira Launches Piperacillin and Tazobactam for Injection in the United States
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... Aug. 28, 2014 Levi & Korsinsky announces ... the United States District Court for the District of ... who purchased Galectin Therapeutics Inc. ("Galectin" or the "Company") ... 28, 2014. For more information, click here: ... during the Class Period the Company violated federal securities ...
(Date:8/28/2014)...   Edison Nation Medical , the premier ... for product ideas to improve the health and ... through the 6-month search ( www.EdisonNationMedical.com/Seniors ) will ... healthcare retailers with whom Edison Nation Medical has ... 65 and older. The objective of ...
(Date:8/28/2014)... CAMBRIDGE, Mass. , Aug. 28, 2014 /PRNewswire/ ... treatments for diseases related to the human microbiome, ... Seres, Executive Vice President of R&D and Chief ... Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). ... implications of SER-109, a novel mixture of bacterial ...
Breaking Medicine Technology:SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against Galectin Therapeutics Inc. and Its Board of Directors and a Lead Plaintiff Deadline of September 29, 2014 -- GALT 2Edison Nation Medical Launches Open Innovation Search to Uncover Innovative Senior Care Products 2Edison Nation Medical Launches Open Innovation Search to Uncover Innovative Senior Care Products 3Seres Health to Present Clinical Findings at ICAAC 2014 Conference 2
... Anthera Pharmaceuticals,announced today they have reached agreement ... on a Phase 3 protocol for varespladib ... FDA,s Special Protocol Assessment,procedure. At the same ... European Medicines Agency (EMEA) on Anthera,s European ...
... Summary: Genmab has Completed Recruitment of Patients in the ... of Ofatumumab in Rituximab Refractory Follicular NHL, COPENHAGEN, ... has completed recruitment of patients in the,pivotal Phase III ... (NHL). Eighty-one patients,receiving treatment at the 1000 mg dose ...
Cached Medicine Technology:Anthera Completes Special Protocol Assessment With FDA and Receives EMEA Scientific Advice on Development Path Toward Varespladib Approval 2Anthera Completes Special Protocol Assessment With FDA and Receives EMEA Scientific Advice on Development Path Toward Varespladib Approval 3Recruitment Completed in Ofatumumab NHL Pivotal Study 2Recruitment Completed in Ofatumumab NHL Pivotal Study 3
(Date:8/29/2014)... the Arabian Peninsula and spread to Europe several times. ... several hundred people since its discovery in 2012. For ... easily the pathogen spreads from human to human. An ... University of Bonn have now come to the conclusion, ... is low. Still, a third of infected persons with ...
(Date:8/29/2014)... Latham, New York (PRWEB) August 29, 2014 ... addition of Micro-Needling services in their Latham aesthetic office. ... cutting-edge technology, is one of the first surgeons in ... device . The innovative technique is faster and ... , Micro-Needling is a noninvasive procedure ...
(Date:8/29/2014)... FRIDAY, Aug. 29, 2014 (HealthDay News) -- Researchers have ... in their brains. Dyslexia -- the most commonly ... problems with reading and writing. Previous research showed ... but most of those studies focused only on a ... used functional MRI to analyze how multiple brain regions ...
(Date:8/29/2014)... August 29, 2014 Parker Waichman LLP, ... to protecting the rights of victims who have been ... (DEA) has announced new regulations for all hydrocodone combination ... (RAPS) report dated August 21, 2014, the DEA ... drugs under federal law. , The long-awaited announcement ...
(Date:8/29/2014)... (PRWEB) August 29, 2014 Hastings and ... been saving clients’ money for many years is pleased ... settlement of $190,000. With 11 convenient locations throughout the ... always handled by a licensed attorney. In addition, experienced ... when necessary. This level of dedication and service is ...
Breaking Medicine News(10 mins):Health News:MERS: Low transmissibility, dangerous illness 2Health News:MERS: Low transmissibility, dangerous illness 3Health News:Williams Revjuva Center Brings Micro-Needling to Latham 2Health News:Scientists Find Differences in Brains of Those With Dyslexia 2Health News:The Drug Enforcement Agency (DEA) Just Announced Plans to Regulate All Hydrocodone Combination Drugs as Schedule II Drugs, Parker Waichman LLP Comments 2Health News:The Drug Enforcement Agency (DEA) Just Announced Plans to Regulate All Hydrocodone Combination Drugs as Schedule II Drugs, Parker Waichman LLP Comments 3Health News:Hastings and Hastings Is Pleased To Report Having Saved A Client $20,900 On A Settlement Of $190,000 2Health News:Hastings and Hastings Is Pleased To Report Having Saved A Client $20,900 On A Settlement Of $190,000 3
... students and faculty of Indian origin add to the rich ... some 430 km from here, where a gunman went on ... professor of Indian origin. ,Founded in 1872, the ... formally called, has more than 25,000 students from as many ...
... footage on television could intensify stress and trauma, according to// ... terrorist attacks on Sep 11, 2001 in the US, sleep ... Andover, Massachusetts, US, began teaching a class in which students ... remembered them. ,On the day after the ...
... According to Irish researchers, a smoking ban which began March ... a drastic cut //in air pollution, the health of bar ... the researchers gave an 83 percent reduction in air pollution ... addition, the report, which was published in the American Journal ...
... known as otitis media with effusion, which consists// of fluid ... ear infection, according to a report in the April issue ... JAMA/Archives journals. ,Otitis media with effusion, a ... space, but without earache, fever or other symptoms, has become ...
... causal organisms of hitherto common diseases// into ‘superbugs’. This, ... , One such example is the recent announcement by ... has now become resistant to the antibiotic fluoroquinolones. The ... creating worry lines on many a health expert. ...
... daily calcium intake is an effective way of identifying ... of osteoporosis, according to a research.// ,Researchers ... looked at a cross-section of 372 men with prostate ... and 28 per cent had undergone a radical prostatectomy. ...
Cached Medicine News:Health News:Indians Add to Rich Diversity of Virginia Tech 2Health News:Disturbing TV Scenes may Intensify Stress 2Health News:Ireland’s Smoke Ban Seems To Do The Tric 2Health News:Obesity may Be Linked to Middle Ear Effusions in Children 2Health News:Measuring Calcium Intake Help to Identify Osteoporosis in Prostate Cancer Patient 2
A handy, quick reference for physicians, nurses, and other health care providers treating cancer patients....
A handy quick-reference tool for busy residents and clinicians with key facts and points essential for day-to-day patient care....
Provides reliable information on the most commonly prescribed drugs, their side effects, interactions and cost of therapy....
Very concise book answering the question: "I've got a diagnosis, which drugs do I use?". All 15 chapters written by highly skilled US specialists...
Medicine Products: